Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Duineveld, C. A. A."'
Autor:
Avest, M. ter, Bouwmeester, R.N., Duineveld, C., Wijnsma, K.L., Volokhina, E.B., Heuvel, L.P.W.J. van den, Burger, D.M., Wetzels, J.F.M., Adang, E.M.M., Kar, N.C.A.J. van de, Heine, R. ter
Publikováno v:
Nephrology, Dialysis, Transplantation, 38, 362-371
Nephrology, Dialysis, Transplantation, 38, 2, pp. 362-371
Nephrology, Dialysis, Transplantation, 38, 2, pp. 362-371
Contains fulltext : 291080.pdf (Publisher’s version ) (Open Access) BACKGROUND: Eculizumab is a lifesaving yet expensive drug for atypical haemolytic uraemic syndrome (aHUS). Current guidelines advise a fixed-dosing schedule, which can be suboptima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::53f952ce6676fb536d59421892a392d4
http://hdl.handle.net/2066/291080
http://hdl.handle.net/2066/291080
Autor:
Avest, M. ter, Steenbreker, H., Bouwmeester, R.N., Duineveld, C., Wijnsma, K.L., Heuvel, L.P.W.J. van den, Langemeijer, S.M.C., Wetzels, J.F.M., Kar, N.C.A.J. van de, Heine, R. ter
Publikováno v:
Clinical Journal of the American Society of Nephrology, 18, 6, pp. 759-766
Clinical Journal of the American Society of Nephrology, 18, 759-766
Clinical Journal of the American Society of Nephrology, 18, 759-766
Item does not contain fulltext BACKGROUND: Eculizumab is a monoclonal antibody for the treatment of atypical hemolytic uremic syndrome (aHUS). Kidney damage, a common condition in patients with aHUS, may result in proteinuria. Because proteinuria may
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1eef95f3b8662398bbb229d9db0747e4
https://repository.ubn.ru.nl/handle/2066/293811
https://repository.ubn.ru.nl/handle/2066/293811
Autor:
Bouwmeester, R.N., Duineveld, C., Wijnsma, K.L., Bemelman, F.J., Heijden, J.W. van der, Wijk, J.A.E. van, Bouts, A.H.M., Wetering, J. van de, Dorresteijn, E., Berger, S.P., Gracchi, V., Zuilen, A.D. van, Keijzer-Veen, M.G., Vries, A.P.J. de, Rooij, R.W.G. van, Engels, F.A.P.T., Altena, W., Wildt, R. de, Kempen, E. van, Adang, E.M., Avest, M. ter, Heine, R. ter, Volokhina, E.B., Heuvel, L.P.W.J. van den, Wetzels, J.F.M., Kar, N.C.A.J. van de
Publikováno v:
Bouwmeester, R N, Duineveld, C, Wijnsma, K L, Bemelman, F J, van der Heijden, J W, van Wijk, J A E, Bouts, A H M, van de Wetering, J, Dorresteijn, E, Berger, S P, Gracchi, V, van Zuilen, A D, Keijzer-Veen, M G, de Vries, A P J, van Rooij, R W G, Engels, F A P T, Altena, W, de Wildt, R, van Kempen, E, Adang, E M, ter Avest, M, ter Heine, R, Volokhina, E B, van den Heuvel, L P W J, Wetzels, J F M & van de Kar, N C A J 2022, ' Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective : Results of the CUREiHUS Study ', Kidney International Reports, vol. 8, no. 1, pp. 91-102 . https://doi.org/10.1016/j.ekir.2022.10.013
Kidney International Reports, 8(1), 91-102. Elsevier Inc.
Kidney International Reports, 8, 1, pp. 91-102
Kidney International Reports, 8(1), 91-102. Elsevier Science
Kidney International Reports, 8(1), 91-102. ELSEVIER SCIENCE INC
Kidney International Reports, 8, 91-102
Kidney International Reports. Elsevier Inc.
Kidney International Reports, 8(1), 91-102. Elsevier Inc.
Kidney International Reports, 8, 1, pp. 91-102
Kidney International Reports, 8(1), 91-102. Elsevier Science
Kidney International Reports, 8(1), 91-102. ELSEVIER SCIENCE INC
Kidney International Reports, 8, 91-102
Kidney International Reports. Elsevier Inc.
Introduction: The introduction of eculizumab has improved the outcome in patients with atypical hemo-lytic uremic syndrome (aHUS). The optimal treatment strategy is debated. Here, we report the results of the CUREiHUS study, a 4-year prospective, obs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da7d699e40d5937c24775971a41a47d3
https://hdl.handle.net/1887/3563249
https://hdl.handle.net/1887/3563249
Autor:
Bouwmeester, R.N., Bormans, E.M.G., Duineveld, C., Zuilen, A.D. van, Logt, A. van de, Wetzels, J.F.M., Kar, N.C.A.J. van de
Publikováno v:
Frontiers in Immunology, 13
IntroductionCOVID-19 vaccination has been associated with rare but severe complications characterized by thrombosis and thrombocytopenia.Methods and ResultsHere we present three patients who developed de novo or relapse atypical hemolytic uremic synd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0da45c8e2ea8b8af6a31f8ecd581ca2
http://hdl.handle.net/2066/286835
http://hdl.handle.net/2066/286835
Publikováno v:
Pediatric Nephrology, 34, 741-742
Pediatric Nephrology, 34, 4, pp. 741-742
Pediatric Nephrology, 34, 4, pp. 741-742
Contains fulltext : 202652-corr.pdf (Publisher’s version ) (Open Access) Contains fulltext : 202652.pdf (Publisher’s version ) (Open Access) The original version of this article unfortunately contained two mistakes. The presentation of Table 1 an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1d15e8f0a6d633ea73d4316f67bf1896
http://hdl.handle.net/2066/202652
http://hdl.handle.net/2066/202652
Publikováno v:
Chemometrics and Intelligent Laboratory Systems, 19(3), 309-318. ELSEVIER SCIENCE BV
The construction of a small experimental design for a combination of process and mixture variables is a problem which has not been solved completely by now. In a previous paper we evaluated some designs with theoretical measures. This second paper ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::c87799a666bb97d9dc49fec4ea71b903
https://research.rug.nl/en/publications/c24da977-aff1-4c43-b2dd-59fb52823470
https://research.rug.nl/en/publications/c24da977-aff1-4c43-b2dd-59fb52823470
Publikováno v:
Chemometrics and Intelligent Laboratory Systems, 19(3), 295-308. ELSEVIER SCIENCE BV
The combination of process variables and mixture variables in experimental design is a problem which has not yet been solved. It is examined here whether a set of designs can be found which can be used for a series of models of reasonable complexity.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::539415d45de8b90b935d17fa1e369f3d
https://research.rug.nl/en/publications/bb9f3129-8837-426e-aa93-f02793cc97c9
https://research.rug.nl/en/publications/bb9f3129-8837-426e-aa93-f02793cc97c9
Publikováno v:
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 19(3), 309-318. Elsevier
The construction of a small experimental design for a combination of process and mixture variables is a problem which has not been solved completely by now. In a previous paper we evaluated some designs with theoretical measures. This second paper ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::3803fb0943b7ef0c4e88a46fa5ea395f
https://pure.amc.nl/en/publications/comparison-of-experimentaldesigns-combining-process-and-mixture-variables-2-design-evaluation-on-measured-data(71e24f74-47f8-4894-9d44-eac99fc18c50).html
https://pure.amc.nl/en/publications/comparison-of-experimentaldesigns-combining-process-and-mixture-variables-2-design-evaluation-on-measured-data(71e24f74-47f8-4894-9d44-eac99fc18c50).html
Publikováno v:
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 19(3), 295-308. Elsevier
The combination of process variables and mixture variables in experimental design is a problem which has not yet been solved. It is examined here whether a set of designs can be found which can be used for a series of models of reasonable complexity.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::b884faad87fd64465bb078228e247192
https://pure.amc.nl/en/publications/comparison-of-experimentaldesigns-combining-process-and-mixture-variables-1-design-construction-and-theoretical-evaluation(e5f328a4-871f-4bfc-a263-f3ccb029754d).html
https://pure.amc.nl/en/publications/comparison-of-experimentaldesigns-combining-process-and-mixture-variables-1-design-construction-and-theoretical-evaluation(e5f328a4-871f-4bfc-a263-f3ccb029754d).html
Autor:
Bos, C. E., BOLHUIS, G. K., LERK, C. F., de Boer, J. H., DUINEVELD, C. A. A., Smilde, A. K., Doornbos, D. A.
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics, 37(4), 210-215. ELSEVIER SCIENCE BV
European journal of pharmaceutics and biopharmaceutics, 37(4), 210-215. Elsevier
European journal of pharmaceutics and biopharmaceutics, 37(4), 210-215. Elsevier
A factorial design has been used to study the influence of disintegrant concentration, storage temperature and relative humidity upon storage on the physical stability of tablets prepared by direct compression. Tablets prepared from a binary mixture
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ad80ecb78eb92d62de06f766102d4383
https://research.rug.nl/en/publications/022c6530-0775-42e1-bc35-0ef2b6815eda
https://research.rug.nl/en/publications/022c6530-0775-42e1-bc35-0ef2b6815eda